How will data about me be collected if I decide to join the study?

During your participation in the study, you will provide personal data about yourself, such as information on your
medical condition and medical history, to the study nurses at your study visits (and relevant blood and urine test results held at your hospital). We will also record and store your contact details, such as your email address, to communicate with you about the EASi-KIDNEY^TM trial and we will ask you if these contact details can be used after the study has ended to ask you for updated information about your health and to invite you to future studies. These data will be entered into a computer system managed by the University of Oxford and stored securely. Only staff with appropriate training and permission can access this computer system and the information stored within it.

In addition, the coordinating centre in Oxford will ask for information about your health from your doctors, registries (such as the UK Renal Registry), NHS England (or other central NHS bodies), and the NHS Diabetic Eye Screening Programme (if you have diabetes). The EASi-KIDNEY^TM team send your name, date of birth, NHS number (or CHI number in Scotland, or H&C number in Northern Ireland) and postcode to NHS England (or another central NHS body) who can link this information to individual participants in the study.

These sources can provide information about people who have died which may mean the study team does not make contact and cause any distress to relatives. Your name, date of birth, NHS number (or CHI number in Scotland or H&C number in Northern Ireland) and postcode will be stored securely by the University of Oxford for the purposes of this linkage. Personal identifiers will NOT be sent to anyone else (including Boehringer Ingelheim, the drug company who make empagliflozin and vicadrostat, also known as BI 690517).

At any time, you may decide you are no longer willing to attend the study clinic. In this case, the local study team will ask if they can continue to contact you or a relative by telephone or access your medical records to continue to collect information about your health in relation to the EASi-KIDNEY^TM trial. You may also contact the study team to withdraw permission for the study to get this information about you (see back page for contact details) but we will keep information about you that we have already collected.